Art

J-GLOBAL ID：201102234618595421   Reference number：11A1146674

Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer

いずれかの薬物治療ラインにおけるフッ化ピリミジン,白金製剤,タキサン類,およびイリノテカンの使用と進行胃癌の予後の関連性

Author (13)： SHITARA Kohei (Aichi Cancer Center Hospital, Aichi, JPN) ,  MATSUO Keitaro (Aichi Cancer Center Res. Inst., Nagoya, JPN) ,  MIZOTA Ayako (Aichi Cancer Center Hospital, Aichi, JPN) ,  KONDO Chihiro (Aichi Cancer Center Hospital, Aichi, JPN) ,  NOMURA Motoo (Aichi Cancer Center Hospital, Aichi, JPN) ,  TAKAHARI Daisuke (Aichi Cancer Center Hospital, Aichi, JPN) ,  YOKOTA Tomoya (Aichi Cancer Center Hospital, Aichi, JPN) ,  URA Takashi (Aichi Cancer Center Hospital, Aichi, JPN) ,  ITO Seiji (Aichi Cancer Center Hospital, Aichi, JPN) ,  SAWAKI Akira (Aichi Cancer Center Hospital, Aichi, JPN) ,  TAJIKA Masahiro (Aichi Cancer Center Hospital, Aichi, JPN) ,  KAWAI Hiroki (Aichi Cancer Center Hospital, Aichi, JPN) ,  MURO Kei (Aichi Cancer Center Hospital, Aichi, JPN)
Material： Gastric Cancer
Volume： 14  Issue： 2  Page： 155-160  Publication year： 2011 
JST Material Number： L7803A  ISSN： 1436-3291  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Progressive gastric carcinoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1146674&from=J-GLOBAL&jstjournalNo=L7803A") }}

JST classification (2)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (3)： Fluorouracil ,  Paclitaxel ,  Irinotecan

Reference (19)：

• 1. International Agency for Research on Cancer GLOBOCAN 2008. http://www-dep.iarc.fr/CancerMondial.htm.
• 2. Van Cutsem E, Moiseyenko VM, Tjulandin S, Maths A, Cons-tenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol. 2006;24:4991-7.
• 3. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagoga-stric cancer. N Engl J Med. 2008;358:36-46.
• 4. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatm versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215-21.
• 5. Kang YK, Kang WK, Shin DB, Chen J, Xiong J, Wang J, et al. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009;20:666-73.

Terms in the title (8)： 薬物治療 ,  ピリミジン ,  白金製剤 ,  タキサン類 ,  イリノテカン ,  進行胃癌 ,  予後 ,  関連性